Response to platinum-based chemotherapy has been noted to be substantially greater for patients with Ki-67 proliferation index of > 55%, which most often corresponds to NEC, whereas surgery has been associated with better survival for G3 GEP-NETs than for GEP-NEC27–29. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.